In summary, our results show that HMGN2 is involved in the transcriptional regulation of CDC20 by modulating the acetylation level of H3K27 in the CDC20 promoter region, thereby affecting the cell cycle distribution and proliferative ability of gliomas. The gene discussed is HMGN2; the disease is central nervous system cancer.